Smith Bryan E. has filed 6 insider transactions across 1 company since February 2023.
Most recent transaction: a grant/award of 150500 shares of Eledon Pharmaceuticals, Inc. ($ELDN) on January 10, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 10, 2025 | Eledon Pharmaceuticals, Inc. | $ELDN | Smith Bryan E. | General Counsel, Corporate Sec | A | Stock Option (right to buy) | 150500 | $0.00 | 150,500.0000 | 48,543,787 | 9999.99% | 0.31% |
| Jan. 10, 2025 | Eledon Pharmaceuticals, Inc. | $ELDN | Smith Bryan E. | General Counsel, Corporate Sec | A | Restricted Stock Units | 64500 | $0.00 | 64,500.0000 | 48,543,787 | 9999.99% | 0.13% |
| Nov. 21, 2024 | Eledon Pharmaceuticals, Inc. | $ELDN | Smith Bryan E. | General Counsel, Corporate Sec | A | Stock Option (right to buy) | 474350 | $0.00 | 474,350.0000 | 51,945,920 | 9999.99% | 0.91% |
| June 13, 2024 | Eledon Pharmaceuticals, Inc. | $ELDN | Smith Bryan E. | General Counsel, Corporate Sec | A | Stock Option (right to buy) | 241650 | $0.00 | 241,650.0000 | 24,619,197 | 9999.99% | 0.98% |
| May 1, 2023 | Eledon Pharmaceuticals, Inc. | $ELDN | Smith Bryan E. | General Counsel, Corporate Sec | A | Stock Option (right to buy) | 179000 | $0.00 | 179,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2023 | Eledon Pharmaceuticals, Inc. | $ELDN | Smith Bryan E. | General Counsel, Corporate Sec | A | Stock Option (right to buy) | 155000 | $0.00 | 155,000.0000 | 0 | 9999.99% | 0.00% |